Board Changes | 23-Jul-2024 | 07:05 | RNS |
Revenue growth of 24% in H1 with 55% now recurring | 23-Jul-2024 | 07:00 | RNS |
Senior Management Appointments | 11-Jul-2024 | 07:00 | RNS |
PDMR Shareholding/SIP and Total Voting Rights | 01-Jul-2024 | 07:00 | RNS |
Result of AGM | 24-Jun-2024 | 13:15 | RNS |
Diaceutics - Capital Markets Event | 06-Jun-2024 | 07:00 | RNS |
Notice of AGM and Posting of Annual Report | 29-May-2024 | 08:00 | RNS |
Data to be Presented at 2024 ASCO Annual Meeting | 28-May-2024 | 07:00 | RNS |
PDMR Shareholding/SIP and Total Voting Rights | 24-May-2024 | 15:01 | RNS |
Director / PDMR Shareholding | 23-May-2024 | 07:00 | RNS |
Revenue growth of 22% & order book growth of 57% | 21-May-2024 | 07:00 | RNS |
Two New Enterprise-Wide Engagements | 16-May-2024 | 07:00 | RNS |
Diaceutics - Capital Markets Event | 14-May-2024 | 07:00 | RNS |
Notice of Results & Presentations | 01-May-2024 | 07:00 | RNS |
PDMR Shareholding/SIP and TVR | 30-Apr-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 131.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 134.00p |
52 Week Low | 83.50p |
Volume | 89,328 |
Shares Issued | 84.68m |
Market Cap | £110.93m |
RiskGrade | 196 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
08:33 | 35,570 @ 131.00p |
14:34 | 5,000 @ 131.00p |
14:00 | 10,000 @ 131.00p |
14:00 | 10,000 @ 131.00p |
13:17 | 150 @ 131.00p |
CEO | Ryan Gerard Keeling |
CFO | Nick Roberts |
You are here: research